Influenza Vaccine

The Ignite P303 Trial will look at the safety and immune response of an mRNA-based investigational vaccine aimed at preventing seasonal flu in adults aged 18 and older.

Who Can Join?

This clinical trial is looking for healthy adult participants. To join, you must be:

  • 18 years of age or older
  • In good health
  • Not pregnant or planning on becoming pregnant for at least 3 months following your vaccine visit

What to Expect

Your participation in the Ignite P303 Trial will last up to 7 months.

  • You will have at least 3 clinic visits and 2 scheduled phone calls to check in about any side effects
  • You will be given 1 injection in the upper arm
  • You must complete an electronic diary (eDiary) entry every day for 7 days, starting on and including the day of injection
  • Qualified participants will receive payment for their trial-related time and travel

Other Considerations

Prior to enrolling in this clinical trial, you should:

  • Not have received a seasonal flu vaccine in the past 5 months
  • Not have had a confirmed flu infection within 6 months